PTP1B deficiency enhances liver growth during suckling by increasing the expression of insulin-like growth factor-I

Fernando Escrivá1, Agueda González-Rodriguez, Elisa Fernández-Millán

  • 1Centro de Investigación Biomédica en Red de Diabetes y Enferemdades Metabólicas Asociadas, Instituto de Salud Carlos III, Madrid, Spain.

Insights

Protein tyrosine phosphatase 1B (PTP1B) deficiency enhances neonatal liver growth and glucose metabolism via the pentose phosphate pathway. This suggests PTP1B uniquely controls early liver development.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Developmental Biology

Background:

  • Protein tyrosine phosphatase 1B (PTP1B) negatively regulates insulin and growth factor signaling.
  • Previous studies showed PTP1B deficiency impacts glucose uptake in neonatal hepatocytes.

Purpose of the Study:

  • Investigate the role of PTP1B in intrahepatic glucose utilization and liver development in neonatal mice.
  • Determine the molecular mechanisms underlying PTP1B's effects on neonatal liver physiology.

Main Methods:

  • Comparative analysis of wild-type and PTP1B(-/-) neonatal mice (3-5 days old).
  • Biochemical assays for glycogen, lactate, pyruvate, and triglyceride content.
  • Enzyme activity assays (G6PD).
  • Molecular analyses including gene and protein expression (STAT 5B, IGF-I, IGF-IR, PCNA).
  • Embryo transfer experiments to assess maternal vs. embryonic PTP1B roles.

Main Results:

  • PTP1B deficiency decreased liver glycogen, lactate, and pyruvate but increased glucose 6-phosphate dehydrogenase (G6PD) activity in neonatal mice.
  • Enhanced STAT 5B phosphorylation, IGF-I signaling, and PCNA expression were observed in PTP1B-deficient livers.
  • Increased liver weight, DNA content, and liver-to-body mass ratio in PTP1B(-/-) neonates.
  • Elevated hepatic and serum triglycerides in PTP1B(-/-) mice, linked to maternal milk composition.
  • Embryo transfer studies indicated maternal PTP1B influences neonatal fat accumulation, but not liver growth or metabolic changes.

Conclusions:

  • PTP1B plays a critical role in regulating neonatal liver development and glucose metabolism.
  • PTP1B deficiency promotes liver growth and alters metabolic pathways through effects on G6PD and the IGF-I axis.
  • Maternal PTP1B influences neonatal hepatic fat accumulation, suggesting a complex interplay between maternal and embryonic factors.

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...